# V1 Empirics Check — x-ai/grok-4.1-fast (Variant A)

**Model:** x-ai/grok-4.1-fast
**Variant:** A
**Date:** 2026-04-02T00:35:48.826354

---

### 1. Idea Fidelity
The paper deviates substantially from the original idea manifest. The manifest promised an analysis of how the Alice shock pushed small entities out of the innovation system, focusing on application abandonment rates at the art-unit × quarter × entity-type level, applicant exit, and technology reallocation. It emphasized the distributional effects on small vs. large entities (e.g., 77% abandonment for small entities facing §101 rejections vs. 46.7% for large), using BigQuery PatEx + Office Actions data in a continuous-treatment DiD within TC 36. This paper instead examines changes in examiners' §101 rejection rates across art units (with §103 as placebo), omitting all entity-type variation, abandonment outcomes, and innovation recomposition. While it retains the within-TC continuous-treatment DiD framework, pre-trends test, §103 placebo, and cross-TC robustness (TC 36 vs. 17), it misses the core research question on small-entity exit and uses Office Action datasets without PatEx integration for applicant outcomes. This shift reframes the paper from innovation effects to examiner behavior, undermining fidelity.

### 2. Summary
This paper exploits sharp within-Technology Center 3600 (business methods/software) variation in post-Alice §101 rejection intensity across 71 art units to estimate how the 2014 Alice decision reshaped patent prosecution. Using a continuous-treatment difference-in-differences design—with the art-unit-level pre-to-post §101 rejection rate change as treatment—it documents large, persistent increases in §101 rejections (mechanically scaling with treatment) and substitution away from §103 rejections, validated by parallel pre-trends claims and cross-TC comparisons to chemistry (TC 1600). The findings highlight "eligibility traps" in high-shock art units like financial data processing, contributing novel evidence on heterogeneous doctrinal enforcement inside the USPTO examination process.

### 3. Essential Points
The paper has three critical flaws that must be addressed for any chance of revision; failure to fix them warrants rejection.

1. **Tautological main identification**: The continuous-treatment specification regresses the §101 rejection rate \(Y_{a,t}\) on \(AliceShock_a \times Post_t\), where \(AliceShock_a\) is defined as the art unit's own average post-pre §101 rate change. This yields \(\beta \approx 1\) mechanically in the post-period (explicitly 1.000 in Table 3, Col. 2, with SE=0), as high-shock units are defined by larger post-period \(Y\). It identifies nothing causal about Alice's effect—it merely confirms definitional divergence. Reframe as a descriptive event study of heterogeneity or instrument the shock (e.g., via pre-Alice technology proxies or examiner fixed effects); otherwise, discard the continuous DiD.

2. **Missing evidence on parallel trends and dynamics**: Claims of "no significant pre-trends across 10 pre-treatment quarters" are unsupported—no event-study coefficients, figures, or tests are shown (Eq. 3 is described but absent). Table 1 summaries show high pre-Alice §101 dispersion (SD=0.208), raising doubts about baseline parallelism. Provide full event-study results (e.g., plot \(\beta_k\) from Eq. 3 with 95% CIs) and formal pre-trend tests (e.g., joint \(F\)-test on pre-coefficients).

3. **Disconnect from innovation/research question**: The paper analyzes examiner rejection propensities, not applicant responses or innovation (promised in manifest and intro: "filter the patent system," "promote innovation"). No abandonment, grant, or entity-size outcomes; volume effects (Table 1, Col. 3) are suggestive but unlinked to behavior. Match the empirical approach to the question by adding applicant-level outcomes (e.g., abandonment by small/large entity using PatEx) or explicitly pivot to a descriptive examiner-compliance paper.

### 4. Suggestions
While the core variation—massive within-TC §101 shocks (e.g., +55pp in art unit 3694 vs. -9pp in 3668, Table 2)—is compelling and novel, the execution needs substantial polishing for AER: Insights. Prioritize visuals: Add an event-study figure plotting average §101 rates for high-shock (>20pp, n=24) vs. low-shock (<5pp, n=41) art units over 20 quarters, with a vertical line at 2014Q3 and binned continuous-shock bins (e.g., terciles) for nuance. This would vividly show divergence (per smoke test: TC36 quarterly §101 from 10.6% to 31.8%) and test pre-trends non-parametrically, replacing vague claims.

Expand robustness meaningfully. The §103 placebo is a highlight (negative substitution suggests examiners prioritized eligibility over prior art—discuss implications for exam quality, citing Sampat 2019). But Table 3 has mismatched columns (e.g., "Cross-TC" repeats Table 1 Col. 4; small N=126-170 implies unbalanced panel or averaging—clarify obs calculation, as 71 units × 20 quarters ≈1,420). Add: (i) examiner FE to absorb individual compliance (manifest promised examiner IV); (ii) placebo on §102/§112; (iii) falsification excluding top/bottom shock deciles; (iv) dynamic cross-TC DiD (TC3600 shock × event time vs. TC1600). Weighting by action volume (mentioned but coefficients=1.00?) is good—tabulate all promised checks (e.g., drop 2014Q3).

Data transparency is strong (API details, variable construction), but align with manifest: Integrate PatEx for abandonment/grant rates by entity size (small_entity_indicator), enabling small-entity DiD (e.g., interact shock × Post × Small). This would restore fidelity, testing if high shocks raise small-entity abandonment disproportionately (77% vs. 46% hint). Compute shocks per-filing cohort (filed pre/post-Alice) to address composition (intro mentions rerouting risk—test via filing volumes by origin art unit).

Refine framing: Intro overclaims causality ("Alice exposure operates almost mechanically"); tone to "documents heterogeneity in examiner response to Alice guidance." Broaden contributions: Link §101 traps to innovation filtering (cite Caskurlu-Ruane 2022 aggregate work positively, noting your finer ID). Discussion is thoughtful (welfare ambiguity)—add back-of-envelope: High-shock units' 90%+ §101 rates imply ~50% abandonment costs (assuming 50% amend success), scaled to TC3600's 83k apps.

Tables need fixes: Unify Table 1/3/robustness (e.g., continuous shock throughout); report means/SD by high/low bins; add R², #clusters (71?). Appendix SDE table is innovative but tangential—move to online supplement. Abstract: Quantify "large" (e.g., 1-SD shock raises §101 by 20pp). JEL/keywords fine.

Overall, the idea's granularity (art-unit shocks) is AER-worthy if de-mechanized and linked to applicants/innovation. With event studies, small-entity extension, and non-tautological spec, it could shine; current version feels preliminary. Revise-and-resubmit potential high with these changes.
